Tesamorelin — 20mg
Product Overview
Tesamorelin is a synthetic analogue of growth-hormone-releasing hormone (GHRH) engineered for greater stability than native GHRH.
Research Background
GHRH receptor activation is studied in relation to pulsatile growth-hormone release and downstream endocrine signalling. Published research includes receptor pharmacology, hormone-pulse analysis and regulated clinical studies.
Current Areas of Investigation
Laboratory work may examine GHRH-receptor activation, pituitary signalling, pulse dynamics, peptide stability and downstream growth-hormone/IGF-1-axis measurements.
In Plain Language
Researchers are studying how tesamorelin stimulates pulsatile growth-hormone signalling and how that pathway relates to fat distribution, metabolism and downstream IGF-1 responses. Because it acts through the GHRH receptor, it is useful for studying the body’s regulated hormone-release system rather than direct growth-hormone exposure.
In plain terms, tesamorelin research examines how restoring or increasing normal-style growth-hormone pulses may influence visceral fat, lipid metabolism, liver-fat measures and body-composition signals. Researchers also monitor glucose regulation and other downstream endocrine effects.
Product Specifications
- Catalogue No.: TSM5
- Vial Size: 20mg
Quality & Documentation
Lot-specific product documentation and Certificate of Analysis (COA) information may be available through AURAPEP where applicable.
Research Use Only
RESEARCH USE ONLY — NOT FOR HUMAN CONSUMPTION. Supplied strictly for laboratory, analytical and research purposes. Not intended for self-administration or to diagnose, treat, cure or prevent any disease.
